Mesenchymal stromal cells expressing ErbB-2/neu elicit protective antibreast tumor immunity in vivo, which is paradoxically suppressed by IFN-gamma and tumor necrosis factor-alpha priming.

MLA

Romieu-Mourez, Raphaëlle, et al. “Mesenchymal Stromal Cells Expressing ErbB-2/Neu Elicit Protective Antibreast Tumor Immunity in Vivo, Which Is Paradoxically Suppressed by IFN-Gamma and Tumor Necrosis Factor-Alpha Priming.” Cancer Research, vol. 70, no. 20, Oct. 2010, pp. 7742–47. EBSCOhost, https://doi.org/10.1158/0008-5472.CAN-10-0296.

APA

Romieu-Mourez, R., François, M., Abate, A., Boivin, M.-N., Birman, E., Bailey, D., Bramson, J. L., Forner, K., Young, Y.-K., Medin, J. A., & Galipeau, J. (2010). Mesenchymal stromal cells expressing ErbB-2/neu elicit protective antibreast tumor immunity in vivo, which is paradoxically suppressed by IFN-gamma and tumor necrosis factor-alpha priming. Cancer Research, 70(20), 7742–7747. https://doi.org/10.1158/0008-5472.CAN-10-0296

Chicago

Romieu-Mourez, Raphaëlle, Moïra François, Amanda Abate, Marie-Noëlle Boivin, Elena Birman, Dana Bailey, Jonathan L Bramson, et al. 2010. “Mesenchymal Stromal Cells Expressing ErbB-2/Neu Elicit Protective Antibreast Tumor Immunity in Vivo, Which Is Paradoxically Suppressed by IFN-Gamma and Tumor Necrosis Factor-Alpha Priming.” Cancer Research 70 (20): 7742–47. doi:10.1158/0008-5472.CAN-10-0296.